The dismissal narrows the case to retaliation claims only, reducing potential settlement range and legal costs. Monitor discovery developments on remaining claims, but the core disability discrimination theory has been eliminated. No immediate stock impact expected.
Price Chart
Executive Summary
The New York Times won a motion to dismiss two claims in a former employee's lawsuit: disability discrimination under the NYCHRL and FMLA interference. The court found the plaintiff's five-day COVID-19 infection did not qualify as a disability under the NYCHRL, and that she was not denied or discouraged from taking FMLA leave. The case continues on remaining claims (NYCHRL retaliation, NYLL retaliation, FMLA retaliation), but the dismissed claims remove a modest litigation overhang.
Court Ruling Details
Key Facts
- Court granted NYT's motion to dismiss NYCHRL disability discrimination and FMLA interference claims.
- Plaintiff's COVID-19 infection (5-day fever/sore throat) held insufficient to qualify as a disability under NYCHRL.
- Plaintiff received approved FMLA leave and was encouraged to take it by HR; no interference found.
- Remaining claims: NYCHRL retaliation, NYLL retaliation, FMLA retaliation — discovery ongoing.
- No damages awarded; no injunction issued; no financial exposure stated in the opinion.
Financial Impact
No damages awarded or pleaded amount stated in the opinion. Financial exposure not quantified.
Risk Factors
- Remaining retaliation claims (NYCHRL, NYLL, FMLA) could still result in damages if plaintiff prevails at trial or settlement.
- Plaintiff may appeal the dismissal of NYCHRL disability claim (though appeal prospects appear low given clear precedent).
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 court opinion from CourtListener.
| Document | Accession Number |
|---|---|
| COURT-RULING Data (Synthetic) | court-1q12avm9-NYT |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 5, 2026 8w ago | 8-K | $65.48 $67.68 | ▲ +3.36% | ▲ +3.96% | $61.79 (−5.64%) |
Jun 30, 2026 13w ago | Court Ruling | $69.98 $72.37 | ▲ +3.42% | ▲ +4.44% | $61.79 (−11.70%) |
Jun 30, 2026 13w ago | Court Ruling | $69.98 $72.37 | ▲ +3.42% | ▲ +4.44% | $61.79 (−11.70%) |
May 11, 2026 20w ago | Insider Cluster | $74.27 $73.80 | ▼ −0.63% | ▼ −2.74% | $61.79 (−16.80%) |
Apr 13, 2026 24w ago | Court Ruling | $79.30 $77.22 | ▼ −2.62% | ▼ −10.35% | $61.79 (−22.08%) |
Mar 13, 2026 29w ago | DEFA14A | $78.93 $79.30 | ▲ +0.47% | ▼ −3.12% | $61.79 (−21.71%) |
Mar 13, 2026 29w ago | DEFA14A | $78.93 $79.30 | ▲ +0.47% | ▼ −3.12% | $61.79 (−21.71%) |
Mar 3, 2026 30w ago | Insider Cluster | $81.22 $83.74 | ▼ −3.10% | ▼ −7.51% | $61.79 (+23.92%) |
Dec 3, 2025 43w ago | Court Ruling | $64.06 $69.64 | ▲ +8.71% | ▲ +8.79% | $61.79 (−3.54%) |
US Market Status
Subscribe to SecBot
Get Real-Time Court Ruling Intelligence
Market-moving court rulings analyzed within minutes. Patent verdicts, antitrust decisions, class certifications, and more — parsed and scored by AI.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access